Progress in the application of CBCT in the interventional diagnosis and treatment of liver cancer

doi:10.3877/cma.j.issn.2095-5782.2024.03.011

Abstract

Abstract:

Cone-beam computed tomography (CBCT) represents an innovative medical imaging modality capable of capturing high-resolution, anatomically precise three-dimensional images. This technology utilizes a cone-shaped X-ray beam that rotates around the patient, marking a significant advancement from the conventional two-dimensional imaging techniques employed in traditional interventional radiology. CBCT can not only detect small atypical lesions that cannot be detected by CT and MRI, but also search for tumour blood supply arteries and navigate them intraoperatively, and predict the clinical outcome by parenchymal blood volume (PBV) in the immediate postoperative period; in addition, CBCT-guided ablation has gradually shown unique advantages in accuracy, real-time, and reduction of radiation dose when compared to other imaging, which are excellent abilities that play an important role in the precise interventional diagnosis and treatment of liver cancer. The purpose of this article is to review the current progress and clinical value of CBCT in the field of liver cancer intervention.

Key words: Cone-beam computed tomography, Hepatocellular carcinoma, Interventional

Guanyin Ni, Xiaoyun Miao, Jiaan Ding, Pengcheng Tian, Caifang Ni. Progress in the application of CBCT in the interventional diagnosis and treatment of liver cancer[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2024, 12(03): 256-260.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2024.03.011

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2024/V12/I03/256

References 34

[1]	Ning R, Chen B, Yu R, et al. Flat panel detector-based cone-beam volume CT angiography imaging: system evaluation[J]. IEEE Trans Med Imaging, 2000, 19(9): 949-963.
[2]	Floridi C, Radaelli A, Abi-Jaoudeh N, et al. C-arm cone-beam computed tomography in interventional oncology: technical aspects and clinical applications[J]. Radiol Med, 2014, 119(7): 521-532.
[3]	Pellerin O, Pereira H, Van Ngoc Ty C, et al. Is dual-phase C-arm CBCT sufficiently accurate for the diagnosis of colorectal cancer liver metastasis during liver intra-arterial treatment?[J]. Eur Radiol, 2019, 29(10): 5253-5263.
[4]	Schernthaner RE, Lin M, Duran R, et al. Delayed-phase cone-beam ct improves detectability of intrahepatic cholangiocarcinoma during conventional transarterial chemoembolization[J]. Cardiovasc Intervent Radiol, 2015, 38(4): 929-936.
[5]	Yu MH, Kim JH, Yoon JH, et al. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI[J]. Am J Roentgenol, 2013, 201(3): 675-683.
[6]	李桂芬, 孙毅, 赵妍, 等. 锥形束CT增强扫描在结直肠癌肝转移瘤TACE术中的指导作用[J]. 中西医结合肝病杂志, 2022, 32(5): 443-446.
[7]	Miyayama S, Yamashiro M, Ikuno M, et al. Ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinoma guided by automated tumor-feeders detection software: technical success and short-term tumor response[J]. Abdom Imaging, 2014, 39(3): 645-656.
[8]	Pung L, Ahmad M, Mueller K, et al. The role of cone-beam CT in transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis[J]. J Vasc Interv Radiol, 2017, 28(3): 334-341.
[9]	Yao X, Yan D, Jiang X, et al. Dual-phase cone-beam CT-based navigation imaging significantly enhances tumor detectability and aids superselective transarterial chemoembolization of liver cancer[J]. Acad Radiol, 2018, 25(8): 1031-1037.
[10]	Iwazawa J, Ohue S, Hashimoto N, et al. Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma[J]. Eur J Radiol, 2012, 81(12): 3985-3992.
[11]	Ozaki K, Kobayashi S, Matsui O, et al.Extrahepatic arteries originating from hepatic arteries: analysis using CT during hepatic arteriography and visualization on digital subtraction angiography[J]. Cardiovasc Intervent Radiol, 2017, 40(6): 822-830.
[12]	Cho Y, Choi JW, Kwon H, et al. Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the korean liver cancer association[J]. Korean J Radiol, 2023, 24(7): 606-625.
[13]	Minami Y, Murakami T, Kitano M, et al. Cone-beam CT angiography for hepatocellular carcinoma: current status[J]. Dig Dis, 2015, 33(6): 759-764.
[14]	Choi SY, Kim KA, Choi W, et al. Usefulness of cone-beam CT-based liver perfusion mapping for evaluating the response of hepatocellular carcinoma to conventional transarterial chemoembolization[J]. J Clin Med, 2021, 10(4): 713.
[15]	Chen R, Geschwind JF, Wang Z, et al. Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT[J]. J Vasc Interv Radiol, 2013, 24(12): 1837-1844.
[16]	Ruff C, Artzner C, Syha R, et al. Transarterial chemoembolization of hepatocellular carcinoma using radiopaque drug-eluting embolics: impact of embolic density and residual tumor perfusion on tumor recurrence and survival[J]. Cardiovasc Intervent Radiol, 2021, 44(9): 1403-1413.
[17]	Fronda M, Mistretta F, Calandri M, et al. The role of immediate post-procedural cone-beam computed tomography (CBCT) in predicting the early radiologic response of hepatocellular carcinoma (HCC) nodules to drug-eluting bead transarterial chemoembolization (DEB-TACE)[J]. J Clin Med, 2022, 11(23): 7089.
[18]	Syha R, Grözinger G, Grosse U, et al. Parenchymal blood volume assessed by C-arm-based computed tomography in immediate posttreatment evaluation of drug-eluting bead transarterial chemoembolization in hepatocellular carcinoma[J]. Invest Radiol, 2016, 51(2): 121-126.
[19]	Louie JD, Kothary N, Kuo WT,et al. Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization[J]. J Vasc Interv Radiol, 2009, 20(5): 606-613.
[20]	Weissinger M, Vogel J, Kupferschläger J, et al. Correlation of C-arm CT acquired parenchymal blood volume (PBV) with ⁹⁹mTc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up[J]. PLoS One, 2020, 15(12): e0244235.
[21]	Levillain H, Bagni O, Deroose CM, et al. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres[J]. Eur J Nucl Med Mol Imaging, 2021, 48(5): 1570-1584.
[22]	Jafargholi Rangraz E, Tang X, et al. Quantitative comparison of pre-treatment predictive and post-treatment measured dosimetry for selective internal radiation therapy using cone-beam CT for tumor and liver perfusion territory definition[J]. EJNMMI Res, 2020, 10(1): 94.
[23]	Derbel H, Krichen M, Chalaye J, et al. Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT/CT anatomical and volumetric results during the planification of radioembolization for HCC[J]. Eur Radiol, 2023, 33(5): 3510-3520.
[24]	O'Connor PJ, Pasik SD, van der Bom IM, et al. Feasibility of Yttrium-90 radioembolization dose calculation utilizing intra-procedural open trajectory cone beam CT[J]. Cardiovasc Intervent Radiol, 2020, 43(2): 295-301.
[25]	Widmann G, Bodner G, Bale R. Tumour ablation: technical aspects[J]. Cancer Imaging, 2009, No A (Special issue A): S63-67.
[26]	Gordon AC, Lewandowski RJ. CBCT-guided TACE-MWA for HCC measuring up to 5 cm[J]. Acad Radiol, 2021, 28 Suppl 1: S71-72.
[27]	Lyu T, Wang J, Cao S, Song L, et al. Radiofrequency ablation guided by cone beam computed tomography for hepatocellular carcinoma: a comparative study of clinical results with the conventional spiral computed tomography-guided procedure[J]. J Int Med Res, 2019, 47(8): 3699-3708.
[28]	Li Z, Xu K, Zhou X, et al. TACE sequential MWA guided by cone-beam computed tomography in the treatment of small hepatocellular carcinoma under the hepatic dome[J]. BMC Cancer, 2023, 23(1): 600.
[29]	Yuan H, Li X, Tian X, et al. Comparison of Angio-CT and cone-beam CT-guided immediate radiofrequency ablation after transcatheter arterial chemoembolization for large hepatocellular carcinoma[J]. Abdom Radiol (NY), 2020, 45(8): 2585-2592.
[30]	Wong SY, Foley S, Cantwell CP, et al. The effects of cone-beam computed tomography imaging guidance on patient radiation exposures in trans-arterial chemoembolisation for hepatocellular carcinoma[J]. Radiat Prot Dosimetry, 2022, 198(8): 441-447.
[31]	姚雪松, 闫东, 曾辉英, 等. 肝细胞癌TACE治疗中C臂CT扫描X线辐射剂量与时间效率的评估[J]. 肝癌电子杂志, 2014, 1(2): 36-39.
[32]	Miracle AC, Mukherji SK. Conebeam CT of the head and neck, part 1: physical principles[J]. AJNR Am J Neuroradiol, 2009, 30(6): 1088-1095.
[33]	Lin EY, Jones AK, Chintalapani G, et al. Comparative analysis of intra-arterial cone-beam versus conventional computed tomography during hepatic arteriography for transarterial chemoembolization planning[J]. Cardiovasc Intervent Radiol, 2019, 42(4): 591-600.
[34]	Taiji R, Lin EY, Lin YM, et al. Combined angio-CT systems: a roadmap tool for precision therapy in interventional oncology[J]. Radiol Imaging Cancer, 2021, 3(5): e210039.

Please choose a citation manager

Content to export